NCT00001228View on ClinicalTrials.gov

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

October 25, 1988

Study Completion Date

September 6, 2007

Conditions

Islet Cell AdenomaZollinger Ellison Syndrome

Interventions

DRUG

Interferon

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH